This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...